Using the above public single-nuclei RNA-seq data, we show that ATP2B1 was found reduced in COVID-19 patients compared to controls (i.e., 0.507 vs. 0.513 ATP2B1 expression; Fig. EV1H). The gene discussed is ATP2B1; the disease is COVID-19.